MRCG/IPPOSI Steering a course to avoid the ‘Drug Iceberg’ – Report V2

[accordionmenu id=\”uniqueba38695\” accordionmenu=\”732\”]



February 2018

This is the second report from MRCG and IPPOSI on the issue of accessing new and innovative medicines and comes about as a result of a round table meeting hosted in late 2017 with a number of stakeholders from patient organisations, clinicians, industry and the NCPE.

The report from the first meeting of patient organisations alone can be found here

Attached Documents